Enzyme May Hold Key To Successfully Treating Pancreatic Cancer With Targeted Immunotherapy
Tuesday, December 9, 2008 - 20:35
in Biology & Nature
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy. The enzyme is IDO2.